Info@ThinkPinkRocks.org

EKF subsidiary, Selah Genomics’ newly introduced PrecisionPath™ next generation sequencing (NGS) technology cancer test will be a key focus on Booth #19141…

View the original here:
EKF Diagnostics highlighting cancer molecular diagnostics products at ASCO 2015

Scroll to Top